Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Teva (TEVA +0.25%) and Active Biotech (ATVBF.PK) say that early treatment of Multiple Sclerosis...

  • Thursday, March 21, 8:21 AM ET
    Teva (TEVA +0.25%) and Active Biotech (ATVBF.PK) say that early treatment of Multiple Sclerosis with their Laquinimod drug significantly cuts the risk of disability progression in patients, a Phase III trial shows. Additional data from an animal preclinical study demonstrates that laquinimod can restore myelination in the brain and spinal cord. (PR)
Track new comments on this story

This news story has 3 comments:

  •  
    Typical Teva stock behavior: good news it goes up a few cents, bad news it's down a couple bucks. When is this going to change?
    21 Mar, 09:42 AM Reply Like
  •  
    (TEVA) is an Israeli company, and Israel is in a tough time now with Syria, Iran, and maybe Egypt.
    21 Mar, 01:09 PM Reply Like
  •  
    Recent news to add to Pharma pipeline have lifted TEVA to 40 level. Helping others in distress to have a better quality of life. That's so important. Once recognized, we stockholders should benefit too.
    21 Mar, 04:24 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »